FDA Seeks To Amend Drugs' Pregnancy Labeling

Law360, New York (May 29, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has proposed a change of its prescription-drug-labeling regulations that would require labels to include a summary of the risks of use during pregnancy and breast-feeding.

The proposed revisions would give health care professionals more comprehensive information for making prescribing decisions and for counseling women who are pregnant, breast-feeding or of child-bearing age, the FDA said in a statement Wednesday.

Although physician labeling is directed to health care professionals, it is sometimes adapted for use in consumer-directed labeling such as patient...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.